Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Ioannina – page 15

185 clinical trials in Ioannina, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ioannina at a glance
185
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

185 trials in Ioannina

Open in trial search

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Argenx

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:MBS2320
  • Sponsor:Modern Biosciences Limited

Deep vein thrombosis+1

Not recruiting

Study on the Effectiveness and Safety of BAY 3018250 and Low Molecular Weight Heparin for Patients with Proximal Deep Vein Thrombosis

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:BAY 3018250
  • Sponsor:Bayer AG

Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:0–17 years
  • Substances:Aflibercept
  • Sponsor:Bayer AG

Myelofibrosis

Not recruiting

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karyopharm Therapeutics Inc.

Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Gilead Sciences Inc.

IgA nephropathy

Not recruiting

Study on Sibeprenlimab for Patients with IgA Nephropathy

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Sibeprenlimab
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Atacicept
  • Sponsor:Vera Therapeutics Inc.

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Ioannina

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking trials focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Studies evaluating new combination therapies and investigating methods to reduce cardiovascular risks.

  • Heart Failure Prevention
  • Cardiovascular Disease Management
  • Deep Vein Thrombosis

Multiple trials exploring the effectiveness of novel medications in reducing cardiovascular events and improving patient outcomes.

02 Metabolic Disorders

Innovative research targeting obesity and various forms of hypercholesterolemia. Studies include treatments for both adult and pediatric patients with metabolic conditions.

  • Obesity Management
  • Dyslipidemia Treatment
  • Familial Hypercholesterolemia

Clinical investigations focusing on new therapeutic approaches for managing metabolic disorders and their complications.

03 Respiratory Medicine

Advanced studies in asthma and pulmonary fibrosis treatment. Research evaluating new medications for improving lung function and managing severe respiratory conditions.

  • Asthma Control
  • Pulmonary Fibrosis
  • Viral Lung Infections

Trials examining innovative therapies for both acute and chronic respiratory conditions.

04 Hematology

Research focusing on sickle cell disease and beta-thalassemia. Studies evaluating treatments for blood disorders and related complications.

  • Sickle Cell Disease Treatment
  • Iron Overload Management
  • Multiple Myeloma

Comprehensive trials investigating new therapeutic approaches for various blood disorders.

05 Neurological Conditions

Studies investigating treatments for multiple sclerosis and stroke prevention. Research focused on improving neurological outcomes and disease management.

  • Multiple Sclerosis
  • Stroke Prevention
  • Neurological Disorders

Trials evaluating innovative therapies for managing chronic neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.